Loading clinical trials...
Loading clinical trials...
The purpose of this study was to determine the safety, tolerability and pharmacokinetics of ascending single oral doses of JTK-853 administered under fasted or fed conditions in healthy male subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Akros Pharma Inc.
NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched
NCT07545590 · Healthy
NCT07258836 · Neoplasms, Healthy
NCT00090662 · Healthy Volunteer
NCT07059858 · Intellectual Disability, Healthy Subjects
PPD, Phase I Clinic
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions